The role of disposable inhalers in pulmonary drug delivery

被引:16
|
作者
de Boer, Anne H. [1 ]
Hagedoorn, Paul [1 ]
机构
[1] Univ Groningen, Dept Pharmaceut Technol & Biopharm, NL-9713 AV Groningen, Netherlands
关键词
disposable; dry powder inhaler; inhalation; nebuliser; single-dose; single-use; DRY-POWDER INHALERS; CYSTIC-FIBROSIS; COST-EFFECTIVENESS; SOLID DISPERSION; VIRUS-VACCINE; INHALATION; ANTIBIOTICS; FORMULATION; MANAGEMENT; TECHNOLOGY;
D O I
10.1517/17425247.2014.952626
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: There is increasing interest in the pulmonary route for both local and systemically acting drugs, vaccines and diagnostics and new applications may require new inhaler technology to obtain the most therapeutically and/or cost-effective administration. Some of these new applications can benefit from the use of disposable inhalers. Areas covered: Current trends in pulmonary drug delivery are presented in this review as well as the possible contribution of disposable inhalers to the improvement of pulmonary administration therein. Arguments in favour of disposable inhalers and the starting points for development of devices and their formulations are discussed. Also, a brief review of the state of the art regarding current disposable inhaler development is given. Expert opinion: Prerequisites for the use of disposable inhalers, particularly dry powder inhalers, in applications such as childhood vaccination and for preventing or stopping pandemic outbreaks of highly infectious diseases (like influenza, bird flu, SARS) are that they are simple, cheap and effective. Not only do the devices have to be simple in design, but the drug formulations should also be cheap. This may require a different approach as the formulation may not need to be adapted to improve the inhaler must be designed to enhance formulation dispersion.
引用
收藏
页码:143 / 157
页数:15
相关论文
共 50 条
  • [31] The ascent of pulmonary drug delivery
    Gonda, I
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 89 (07) : 940 - 945
  • [32] Advances in Pulmonary Drug Delivery
    Yildiz-Pekoz, Ayca
    Ehrhardt, Carsten
    PHARMACEUTICS, 2020, 12 (10)
  • [33] Nanoparticles for pulmonary drug delivery
    Li, H. Y.
    Jeans, C.
    Birchall, J. C.
    Taylor, G.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 : S20 - S20
  • [34] Fundamentals of pulmonary drug delivery
    Groneberg, DA
    Witt, C
    Wagner, U
    Chung, KF
    Fischer, A
    RESPIRATORY MEDICINE, 2003, 97 (04) : 382 - 387
  • [35] Respiratory Tract: Structure and Attractions for Drug Delivery Using Dry Powder Inhalers
    ElKasabgy, Nermeen A.
    Adel, Islam M.
    Elmeligy, Mohamed F.
    AAPS PHARMSCITECH, 2020, 21 (07)
  • [36] Respiratory Tract: Structure and Attractions for Drug Delivery Using Dry Powder Inhalers
    Nermeen A. ElKasabgy
    Islam M. Adel
    Mohamed F. Elmeligy
    AAPS PharmSciTech, 21
  • [37] Recent advances in drug delivery via pressured metered-dose inhalers
    Pritchard, JN
    OPTIMIZATION OF AEROSOL DRUG DELIVERY, 2003, : 105 - 121
  • [38] The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers
    Weers, Jeffry
    Clark, Andy
    PHARMACEUTICAL RESEARCH, 2017, 34 (03) : 507 - 528
  • [39] The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers
    Jeffry Weers
    Andy Clark
    Pharmaceutical Research, 2017, 34 : 507 - 528
  • [40] DRUG-DELIVERY CHARACTERISTICS OF BRICANYL TURBOHALER(TM) DRY POWDER INHALERS
    MEAKIN, BJ
    CAINEY, JM
    WOODCOCK, PM
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 119 (01) : 91 - 102